Clinical Trials Directory

Trials / Conditions / Relapse/Recurrence

Relapse/Recurrence

15 registered clinical trials studyying Relapse/Recurrence — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingIMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
NCT06713837
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSPhase 3
RecruitingSafety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
NCT06316960
Children's Hospital of Soochow UniversityPhase 2
RecruitingTBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After All
NCT06125483
The First Affiliated Hospital of Soochow UniversityN/A
RecruitingCombined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility
NCT06262386
Chang Gung Memorial HospitalN/A
TerminatedA Biomarker Screening Protocol for Participants With Solid Tumors
NCT05891197
Lyell Immunopharma, Inc.—
UnknownDecitabine and Anti-PD-1 in R/R DLBCL
NCT05816746
Chinese PLA General HospitalPhase 2
TerminatedA Study to Investigate LYL797 in Adults With Solid Tumors
NCT05274451
Lyell Immunopharma, Inc.Phase 1
CompletedMulti-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells
NCT04689659
Beijing Boren HospitalPhase 2
UnknownCamrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma
NCT05320081
Huazhong University of Science and TechnologyPhase 2
UnknownPhase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS
NCT04749355
BioSight Ltd.Phase 2
RecruitingStudy of Lacutamab in Peripheral T-cell Lymphoma
NCT04984837
The Lymphoma Academic Research OrganisationPhase 2
UnknownA Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymp
NCT04860674
Zhejiang Cancer HospitalPhase 2
UnknownDual Target CAR-T Cells in B-cell Lymphoma
NCT04723914
YuLiPhase 1 / Phase 2
CompletedThe Influence of Cancer Stem-cells on Risk of Relapse in Patients Harboring Adenocarcinoma and Squamous Cell C
NCT04634630
Beatrice Aramini—
UnknownPredicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound
NCT03501758
Haukeland University Hospital—